An investigation for investors in OpGen, Inc. (NASDAQ:OPGN) shares over potential securities laws violations by OpGen, Inc. was announced.
San Diego, CA -- (SBWIRE) -- 11/10/2021 -- OpGen, Inc is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of OpGen, Inc. (NASDAQ: OPGN), have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by OpGen, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Rockville, MD based OpGen, Inc., a precision medicine company, engages in developing molecular information products and services in the United States and internationally. OpGen, Inc. reported that its annual Total Revenue rose from $3.49 million in 2019 to $4.21 million in 2020, and that its Net Loss increased from $12.44 million in 2019 to $26.21 million in 2020.
Shares of OpGen, Inc. (NASDAQ: OPGN) declined from $3.55 per share in early 2021 to as low as $1.63 per share on November 9, 2021.
Those who purchased shares of OpGen, Inc. (NASDAQ: OPGN) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.